Quorum Review IRB Launches Site Enrollment Service

Quorum Review IRB, the industry leader in central IRB services, unveils today a unique Site Enrollment Service as part of its 2013 platform of ethics review services.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

QR_Logo

Site start-up that is quick and efficient is mission-critical for our customers. By leveraging the expertise of our site support team, we can help our customers streamline the collection of study start-up documentation.

Seattle, WA (PRWEB) January 02, 2013

Quorum Review IRB, the industry leader in central IRB services, unveils today a unique Site Enrollment Service as part of their 2013 platform of ethics review services.

Quorum’s Site Enrollment Service allows customers to delegate the IRB startup component of clinical research for minimal cost. Quorum Review Site Support personnel will reach out to the research sites identified by the sponsor/CRO to support those sites through the submission process. The sponsor/CRO will receive on-going status updates.

As Quorum Review CEO Cami Gearhart, JD, explains, this service provides a new level of site management within the study start up process. “Site start-up that is quick and efficient is mission-critical for our customers. By leveraging the expertise of our site support team, we can help our customers streamline the collection of study start-up documentation.”

While the service is focused on the initial site submission phase to the IRB, clients have access to the service any time a new site is considered for participation in a central study. More information on the new Site Enrollment Service and all of Quorum’s ethics review services can be found at http://www.quorumreview.com.

About Quorum Review
Quorum Review IRB is an independent ethics review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) and has been providing ethics review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human research subject protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH) and principles of the Belmont Report.

Quorum’s best-in-class service and support includes 14 Board meetings each week plus expedited review, 24 hour site review turnaround, 36 hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s service offerings include full study review in the US and Canada, a specialized Phase I team, institution specific support, and efficient processes for post-approval and registry studies.


Contact